Accrete Pharmaceuticals manufactures and supplies Pazopanib Intermediates in India for pharmaceutical and bulk drug manufacturing requirements. Our product portfolio includes 5-Amino-2-methyl benzene sulfonamide with CAS No. 6973-09-7 and 2,3-Dimethyl-2H-Indazole-6-amine Hydrochloride with CAS No. 635702-60-2.
Incorporated in 2005, Accrete Pharmaceuticals Private Limited was established by a group of committed professionals with an initial focus on anti-cancer products. The company operates a cGMP pharmaceutical intermediate manufacturing facility near Hyderabad, Telangana, India, supporting its pharmaceutical manufacturing and product supply activities.
As a pharmaceutical intermediates manufacturer and supplier, Accrete Pharmaceuticals focuses on product quality, manufacturing practices, proper documentation, customer satisfaction, and a clean manufacturing environment. The company follows established quality methodologies and scientifically derived technologies to support its pharmaceutical intermediate manufacturing operations.
Manufacturing activities are supported by relevant quality procedures and documentation, including equipment validation, process validation, standard operating procedures, and other applicable records. Accrete Pharmaceuticals serves pharmaceutical industry requirements across India and international markets.
Request Product InformationAccrete Pharmaceuticals manufactures and supplies Pazopanib intermediates for pharmaceutical and bulk drug manufacturing requirements. Our product portfolio includes the following chemical intermediates, identified by their respective chemical names and CAS numbers, to support pharmaceutical industry requirements in India and international markets.
5-Amino-2-methyl benzene sulfonamide (CAS No. 6973-09-7) is a chemical intermediate included in the Pazopanib-related pharmaceutical intermediate portfolio of Accrete Pharmaceuticals. The product is offered to support pharmaceutical manufacturing and chemical processing requirements. Contact our team for product specifications, availability and technical information.
Enquire About This Product2,3-Dimethyl-2H-Indazole-6-amine Hydrochloride (CAS No. 635702-60-2) is an indazole-based chemical intermediate associated with Pazopanib manufacturing. Accrete Pharmaceuticals includes this product in its range of pharmaceutical intermediates for industry requirements. Contact us for product specifications, availability and business enquiries.
Enquire About This ProductAccrete Pharmaceuticals is a pharmaceutical intermediate manufacturer in India focused on quality-oriented manufacturing processes, established quality methodologies, and appropriate product documentation.
The company's manufacturing operations are supported by a cGMP facility near Hyderabad, Telangana, India. The facility supports the company's pharmaceutical intermediate portfolio, including its range of Pazopanib Intermediates.
Accrete Pharmaceuticals places emphasis on quality product supply, proper documentation, customer requirements, and scientifically derived technologies across its manufacturing activities.
Discuss Your RequirementsEstablished quality methodologies are followed across pharmaceutical intermediate manufacturing activities.
Manufacturing operations are supported by a cGMP facility located near Hyderabad, Telangana, India.
Appropriate documentation supports product manufacturing and customer requirements.
Manufacturing and supply activities focus on customer requirements and product needs.
Contact Accrete Pharmaceuticals for enquiries related to Pazopanib Intermediates and pharmaceutical intermediate requirements in India.
Discuss Your Product Requirements
Share your requirements with our team for product information and enquiry support.